Khalaf, A;
Hoad, CL;
Menys, A;
Nowak, A;
Radford, S;
Taylor, SA;
Latief, K;
... Moran, GW; + view all
(2020)
Gastrointestinal peptides and small-bowel hypomotility are possible causes for fasting and postprandial symptoms in active Crohn's disease.
The American Journal of Clinical Nutrition
, 111
(1)
pp. 131-140.
10.1093/ajcn/nqz240.
Preview |
Text
Taylor Khalaf et al.pdf - Accepted Version Download (373kB) | Preview |
Preview |
Text
Taylor Supplementray table 1.pdf - Accepted Version Download (139kB) | Preview |
Preview |
Text
Taylor Supplementary figure 1 190619.pdf - Accepted Version Download (148kB) | Preview |
Abstract
BACKGROUND: Crohn's disease (CD) patients suffer postprandial aversive symptoms, which can lead to anorexia and malnutrition. Changes in the regulation of gut hormones and gut dysmotility are believed to play a role. / OBJECTIVES: This study aimed to investigate small-bowel motility and gut peptide responses to a standard test meal in CD by using MRI. / METHODS: We studied 15 CD patients with active disease (age 36 ± 3 y; BMI 26 ± 1 kg/m 2) and 20 healthy volunteers (HVs; age 31 ± 3 years; BMI 24 ± 1 kg/m 2). They underwent baseline and postprandial MRI scans, symptom questionnaires, and blood sampling following a 400-g soup meal (204 kcal). Small-bowel motility, other MRI parameters, and glucagon-like peptide-1 (GLP-1), polypeptide YY (PYY), and cholecystokinin peptides were measured. Data are presented as means ± SEMs. / RESULTS: HVs had significantly higher fasting motility indexes [106 ± 13 arbitrary units (a.u.)], compared with CD participants (70 ± 8 a.u.; P ≤ 0.05). Postprandial small-bowel water content showed a significant time by group interaction (P < 0.05), with CD participants showing higher levels from 210 min postprandially. Fasting concentrations of GLP-1 and PYY were significantly greater in CD participants, compared with HVs [GLP-1, CD 50 ± 8 µg/mL versus HV 13 ± 3 µg/mL (P ≤ 0.0001); PYY, CD 236 ± 16 pg/mL versus HV 118 ± 12 pg/mL (P ≤ 0.0001)]. The meal challenge induced a significant postprandial increase in aversive symptom scores (fullness, distention, bloating, abdominal pain, and sickness) in CD participants compared with HVs (P ≤ 0.05). / CONCLUSIONS: The decrease in fasting small-bowel motility noted in CD participants can be ascribed to the increased fasting gut peptides. A better understanding of the etiology of aversive symptoms in CD will facilitate identification of better therapeutic targets to improve nutritional status. This trial was registered at clinicaltrials.gov as NCT03052465.
Type: | Article |
---|---|
Title: | Gastrointestinal peptides and small-bowel hypomotility are possible causes for fasting and postprandial symptoms in active Crohn's disease |
Location: | United States |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1093/ajcn/nqz240 |
Publisher version: | https://doi.org/10.1093/ajcn/nqz240 |
Language: | English |
Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
Keywords: | magnetic resonance imaging, body mass index procedure, abdominal paincrohn's disease, cell motility, dilatation, pathologic, fasting, intestine, small peptides, postprandial periodhypomotility, glucagon-like peptide 1, microscopes, scanning electron |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Department of Imaging |
URI: | https://discovery.ucl.ac.uk/id/eprint/10085929 |
Archive Staff Only
View Item |